135
Views
21
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Bone and [18F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults

, , , , , & show all
Pages 1794-1802 | Received 11 Mar 2009, Accepted 15 Jul 2009, Published online: 03 Nov 2009

References

  • Shad A, Magrath I. Malignant non-Hodgkin's lymphoma in children. In: Pizzo P, Poplack D, editors. Principles and Practice of Pediatric Oncology, 3rd edn. Philadelphia: Lippincott Raven; 1996. pp 545–587.
  • Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 2004;34:190–198.
  • Lepanto PB, Rosenstock J, Littman P, et al Gallium-67 scans in children with solid tumors. AJR Am J Roentgenol 1976;126:179–186.
  • Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 1984;14:296–323.
  • Tan TX, Gelfand MJ. Ga-67 scintigraphy in pediatric patients. Comparison of extended SPECT of the chest and abdomen with planar imaging. Clin Nucl Med 1996;21:717–719.
  • Orzel JA, Sawaf NW, Richardson ML. Lymphoma of the skeleton: scintigraphic evaluation. AJR Am J Roentgenol. 1988;150:1095–1099.
  • Schechter JP, Jones SE, Woolfenden JM, Lilien DL, O'Mara RE. Bone scanning in lymphoma. Cancer 1976;38:1142–1148.
  • Schwartz CL. The management of Hodgkin disease in the young child. Curr Opin Pediatr 2003;15:10–16.
  • Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy- D-glucose: correlation with CT. Radiology 1994;190:111–116.
  • Bangerter M, Moog F, Buchmann I, et al Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. Ann Oncol 1998;9:1117–1122.
  • Hoh CK, Glaspy J, Rosen P, et al Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997;38:343–348.
  • Bar-Shalom R, Mor M, Yefremov N, Goldsmith SJ. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment. Semin Nucl Med 2001;31:177–190.
  • Buchmann I, Reinhardt M, Elsner K, et al 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001;91:889–899.
  • Schoder H, Meta J, Yap C, et al Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001;42:1139–1143.
  • Montravers F, McNamara D, Landman-Parker J, et al [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002;29:1155–1165.
  • Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004;34:166–179.
  • Friedberg JW, Fischman A, Neuberg D, et al FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Leuk Lymphoma. 2004;45:85–92.
  • Kostakoglu L, Leonard JP, Kuji I, et al Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 2002;94:879–888.
  • Rini JN, Nunez R, Nichols K, et al Coincidence-detection FDG-PET versus gallium in children and young adults with newly diagnosed Hodgkin's disease. Pediatr Radiol 2005;35:169–178.
  • Bar-Sever Z, Keidar Z, Ben Barak A, et al The incremental value of 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 2007;34:630–637.
  • Goodin GS, Shulkin BL, Kaufman RA, McCarville MB. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol 2006;187:1124–1128.
  • Ryan PJ, Fogelman I. The bone scan: where are we now? Semin Nucl Med 1995;25:76–91.
  • Mouratidis B, Gilday DL, Ash JM. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma. Nucl Med Commun 1994;15:144–147.
  • Moog F, Bangerter M, Kotzerke J, et al 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998;16:603–609.
  • Moon TY, Kim EE, Kim YC, et al Comparison of nuclear bone and gallium scans in the therapeutic evaluation of bone lymphoma. Clin Nuc Med 1995;20:721–724.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.